Basel, Switzerland

David Edmonds

USPTO Granted Patents = 7 

Average Co-Inventor Count = 11.2

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Basel, CH (2022 - 2024)
  • Riehen, CH (2024)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
7 patents (USPTO):

Title: The Innovations of David Edmonds - A Visionary Inventor from Basel

Introduction

David Edmonds, an esteemed inventor based in Basel, Switzerland, has made significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of seven patents, he has focused on the development of GLP-1 receptor agonists, which have potential therapeutic applications in treating certain medical conditions.

Latest Patents

Among his latest innovations, David Edmonds has created patents that detail the use of 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, and 7-aza-benzimidazoles as GLP-1R agonists. These patents include processes for synthesizing these compounds and methods for administering them to mammals in need, highlighting the potential impact on improving patient outcomes in specific health scenarios.

Career Highlights

Throughout his career, David has consistently pushed the boundaries of medicinal chemistry. His role at Pfizer Corporation has allowed him to collaborate on groundbreaking projects that aim to improve the lives of many through innovative pharmaceutical solutions.

Collaborations

David Edmonds values collaboration and has worked closely with notable colleagues such as David Andrew Griffith and Scott William Bagley. These partnerships have led to collective advancements in their shared fields, fostering a rich environment of innovation and discovery.

Conclusion

In summary, David Edmonds stands out as a leading inventor in Basel, with a keen focus on GLP-1 receptor agonists. His impressive patent portfolio and collaborations with fellow inventors reflect his commitment to advancing medical research. As he continues to develop new solutions, the impact of his inventions will likely resonate in the pharmaceutical industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…